Vivani Medical (NASDAQ:VANI – Get Free Report) released its quarterly earnings data on Monday. The company reported ($0.11) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.01), Zacks reports.
Vivani Medical Stock Down 3.5 %
Shares of VANI opened at $1.11 on Monday. The company has a 50-day moving average price of $1.14 and a two-hundred day moving average price of $1.21. The stock has a market cap of $65.75 million, a price-to-earnings ratio of -2.47 and a beta of 3.20. Vivani Medical has a 12 month low of $1.03 and a 12 month high of $2.22.
Analyst Ratings Changes
Separately, HC Wainwright reissued a “buy” rating and issued a $4.00 price target on shares of Vivani Medical in a report on Wednesday, March 26th.
About Vivani Medical
Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
Featured Articles
- Five stocks we like better than Vivani Medical
- How to Calculate Return on Investment (ROI)
- Lululemon Pulls Back Into Classic Dip-Buying Opportunity
- What is an Earnings Surprise?
- Cintas Delivers Earnings Beat, Signals More Growth Ahead
- What Are the U.K. Market Holidays? How to Invest and Trade
- Analysts Say These 4 Low P/E Consumer Cyclical Stocks Are Buys
Receive News & Ratings for Vivani Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivani Medical and related companies with MarketBeat.com's FREE daily email newsletter.
